Skip to main content

Table 2 Clinical outcomes (in 30 days)

From: Effect of low-dose exogenous surfactant on infants with acute respiratory distress syndrome after cardiac surgery: a retrospective analysis

Characteristic Surfactant
n = 22
Control
n = 22
P Value
Alive/death (n/n) 22/0 22/0
Complication
 Pneumothorax (%) 2(9) 5(22.7) 0.001
 Digestive tract hemorrhage (%) 0(0) 1(4.5) 0.000
Rescue treatment (%)
 CPAP (%) 3(13.6) 8(36.3) 0.015
 Re tracheal intubation (%) 1(4.5) 2(9) 0.000
 PD (%) 1(4.5) 2(9) 0.000
 HFOV (%) 0(0) 1(4.5) 0.000
Total time on ventilator (h) 133.6 ± 27.2 218.4 ± 28.7 0.000
Total time in PICU (day) 10.7 ± 5.1 17.5 ± 6.8 0.001
  1. Surfactant: patients who had ARDS after cardiac surgery received standard treatment plus exogenous surfactant. Control: patients who had ARDS after cardiac surgery received standard treatment only. The data are presented as mean ± standard; qualitative data are presented as numbers (%)
  2. CPAP treatment with continuous positive airway pressure, PD treatment with peritoneal dialysis, HFOV treatment with high frequency oscillatory ventilator